IRON Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
IRON Financial's BMY Position: Q2 2026 in Review
IRON Financial increased its Bristol-Myers Squibb (BMY) stake by 7% in Q2 2026, buying an estimated $14.8K and bringing the position to 3,949 shares worth $228K. The position accounts for 0.09% of the portfolio, ranked #141.
IRON Financial first reported a position in BMY in Q1 2023 and has held it in 8 quarters since. The position peaked at $734K in Q1 2024. 1,158 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- IRON Financial held 3,949 shares of Bristol-Myers Squibb worth $228K as of Q2 2026.
- IRON Financial bought 258 Bristol-Myers Squibb shares in Q2 2026, an estimated $14.8K.
- Bristol-Myers Squibb made up 0.09% of IRON Financial's portfolio in Q2 2026, its #141 holding.
- IRON Financial first reported a position in Bristol-Myers Squibb in Q1 2023 and has held it in 8 quarters since.
- IRON Financial's Bristol-Myers Squibb position peaked at $734K in Q1 2024.
- 1,158 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on IRON Financial's 13F filing for Q2 2026, filed 22 Jul 2026.